Cardiofaciocutaneous syndrome, commonly called CFC syndrome, is a rare genetic disorder that affects the heart, facial structure, skin, and hair. It occurs in roughly 1 in 200,000 newborns and belongs to a family of conditions known as RASopathies, which all involve the same cell-signaling pathway. CFC syndrome causes a wide range of features that are usually apparent from birth or early infancy, including distinctive facial characteristics, heart defects, skin abnormalities, and developmental delays that range from mild to severe.
The Genetic Cause
CFC syndrome results from a mutation in one of several genes that control a specific cell-growth signaling pathway. The most commonly affected gene is BRAF, but mutations in MAP2K1, MAP2K2, KRAS, and RAF1 can also cause the condition. These genes all play a role in the same chain of signals that tells cells when to grow and divide. When one of them is mutated, the signal stays “on” more than it should, disrupting normal development across multiple organ systems.
The vast majority of cases are de novo, meaning the mutation occurs spontaneously in the child rather than being inherited from a parent. Technically, CFC syndrome follows an autosomal dominant pattern, so only one copy of the mutated gene is needed. But because the condition typically arises as a new mutation, most parents of a child with CFC syndrome do not carry the gene variant themselves.
Facial and Physical Features
Children with CFC syndrome tend to have a recognizable set of facial characteristics. The head is often larger than average (macrocephaly), with a tall forehead that narrows at the temples, increased facial width and depth, coarse features, and a small chin. The overall face shape is sometimes described as triangular. These features may become less pronounced with age.
Hair and skin changes are among the most consistent signs. Nearly all people with CFC syndrome have sparse, curly, woolly, or brittle hair, with thinning at the temples and poor overall growth. Eyebrows are often sparse or absent. Skin tends to be dry and rough, and keratosis pilaris (small bumps on the arms, legs, and face) appears in the majority of cases. Other skin findings include eczema, darkened moles, deep palm and sole creases, thickened skin on the palms and soles, and nails that grow quickly but are brittle or dystrophic.
Heart Involvement
Heart problems are a defining feature of the syndrome and give CFC its name. The most common cardiac issues include pulmonic stenosis (narrowing of the valve that controls blood flow from the heart to the lungs), hypertrophic cardiomyopathy (thickening of the heart muscle), septal defects (holes between heart chambers), and other valve abnormalities. Rhythm disturbances can also develop, sometimes becoming harder to manage over time.
The severity of heart involvement varies widely. Some individuals have mild defects that require only monitoring, while others develop serious complications. Published case reports describe individuals with severe hypertrophic cardiomyopathy who died suddenly in their early twenties from congestive heart failure or untreatable arrhythmias. Heart disease is the primary factor that shortens life expectancy in those with severe cardiac involvement.
Developmental and Neurological Effects
Virtually all children with CFC syndrome experience some degree of developmental delay and cognitive impairment, ranging from mild to severe. Feeding difficulties are common in infancy and early childhood, often involving reflux, vomiting, oral aversion, and aspiration risk. These feeding challenges can contribute to poor growth during the early years.
Low muscle tone (hypotonia) is typical and may affect motor milestones like sitting, crawling, and walking. Seizures occur in a significant number of affected individuals. Eye problems, including crossed eyes, involuntary eye movements, and underdeveloped optic nerves, are also part of the neurological picture. Many children show heightened sensitivity to touch and textures, a feature sometimes called tactile defensiveness.
Cognitive outcomes in adulthood vary. Some individuals complete school with special education support and live semi-independently. One long-term case report in the Journal of Medical Genetics describes a woman with CFC syndrome who graduated from high school in special education and, at age 31, was living in her own apartment space within her family’s home, using appliances, navigating stairs, and managing her daily routine with some support.
How CFC Syndrome Is Diagnosed
There are no formal scoring criteria or checklist that definitively diagnoses CFC syndrome based on physical features alone. Instead, doctors suspect the diagnosis when a child presents with a combination of the characteristic facial features, heart defects, skin and hair abnormalities, feeding difficulties, and developmental delay. The diagnosis is then confirmed through genetic testing that identifies a mutation in one of the associated genes.
CFC syndrome can be difficult to distinguish from two closely related RASopathies: Noonan syndrome and Costello syndrome. All three share overlapping features, but CFC faces tend to be coarser than those seen in Noonan syndrome while usually less coarse than in Costello syndrome. The skin and hair abnormalities in CFC are also more prominent than in other RASopathies. Genetic testing is often the clearest way to tell them apart, since each condition involves different, though sometimes overlapping, gene mutations.
Long-Term Outlook and Daily Life
Life expectancy for people with CFC syndrome depends largely on the severity of heart involvement. Those with mild or well-managed cardiac issues can live into adulthood and beyond. The physical appearance of CFC syndrome tends to change over time: facial features may become less distinctive, and hair can grow thicker and more typical in texture. On the other hand, thickened skin on the palms and soles and lymphedema (fluid-related swelling) may worsen with age.
Because CFC syndrome affects so many body systems, ongoing care typically involves a team of specialists. Regular heart monitoring is essential, particularly for those with hypertrophic cardiomyopathy or rhythm problems. Eye exams, neurological evaluations, skin care, nutritional support for feeding difficulties, and therapies addressing speech, motor skills, and sensory issues all play a role in management. There is currently no cure or targeted treatment for CFC syndrome itself, though each individual symptom can be addressed on its own terms.
Many families are unaware that a significant number of people with CFC syndrome may go undiagnosed because their features are milder or overlap with more common conditions like Noonan syndrome. If a child has unexplained developmental delay alongside heart defects, distinctive facial features, and unusual skin or hair, genetic testing for RASopathies can provide a definitive answer.